Skip to main content

Pyridium Disease Interactions

There are 3 disease interactions with Pyridium (phenazopyridine).

Major

Phenazopyridine (applies to Pyridium) G-6-PD deficiency

Major Potential Hazard, Moderate plausibility.

Patients with glucose-6-phosphate dehydrogenase (G-6-PD) deficiency may be at increased risk for phenazopyridine-induced methemoglobinemia and hemolytic anemia. These conditions have occurred rarely in other patients, except due to acute phenazopyridine overdose or impaired renal function. Therapy with phenazopyridine should be administered cautiously in patients with G-6-PD deficiency.

References

  1. "Product Information. Pyridium (phenazopyridine)." Warner Chilcott Laboratories PROD (2001):
Major

Phenazopyridine (applies to Pyridium) hepatitis

Major Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease

The use of phenazopyridine is contraindicated in patients with severe hepatitis. Rare cases of hepatotoxicity have been associated with phenazopyridine, usually at overdose levels. Hypersensitivity hepatitis has also been reported. Therapy with phenazopyridine should be administered cautiously in patients with impaired hepatic function.

References

  1. "Product Information. Pyridium (phenazopyridine)." Warner Chilcott Laboratories PROD (2001):
Major

Phenazopyridine (applies to Pyridium) renal dysfunction

Major Potential Hazard, High plausibility.

The use of phenazopyridine is contraindicated in patients with impaired renal function. Phenazopyridine is primarily eliminated unchanged by the kidney and may accumulate to toxic levels during prolonged administration in such patients. Reported cases of toxicity due to overdosage have resulted in acute renal failure and methemoglobinemia. Likewise, administration of phenazopyridine to patients with preexisting renal failure has led to methemoglobinemia and hemolytic anemia. Phenazopyridine toxicity may be associated with a yellowish tinge of the skin or sclera.

References

  1. "Product Information. Pyridium (phenazopyridine)." Warner Chilcott Laboratories PROD (2001):

Pyridium drug interactions

There are 56 drug interactions with Pyridium (phenazopyridine).

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer